홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
BNTC
#2504
Benitec Biopharma Inc. Common Stock
10.900
0
-0.05%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.05%
월간 변동
-12.03%
6달 변화
-34.38%
년간 변동율
-34.38%
이전 종가
10.905
0
Open
10.900
0
Bid
Ask
Low
10.900
0
High
10.900
0
양
21
마켓
주식
헬스케어
BNTC
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Cash from operating activities
3.1 M
8.2 M
3.4 M
3.7 M
18.4 M
Cash from investing activities
6 000
0
0
11 K
17 K
Cash from financing activities
28.41 M
2.54 M
0
98.23 M
129.19 M
Free cash flow
3.1 M
8.2 M
3.4 M
3.7 M
18.4 M
뉴스
Gentherapie-Daten stützen Benitec-Aktie: Rating bestätigt
Benitec BioPharma stock rating maintained on gene therapy data
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Benitec BioPharma: Citizens bestätigt Einstufung "Market Outperform"
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
Benitec BioPharma: TD Cowen bestätigt Kaufempfehlung nach starken OPMD-Studiendaten
Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data
Benitec BioPharma: Baird bestätigt "Outperform"-Rating und Kursziel von 30 US-Dollar
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target
Benitec’s gene therapy shows durable results in OPMD patients
Monday’s Insider Moves: Dolphin CEO’s Big Bet Amid Notable Sells